SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-045464
Filing Date
2020-12-30
Accepted
2020-12-30 16:57:36
Documents
3
Period of Report
2020-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea132345-8k_inmune.htm 8-K 75237
2 CERTIFICATE OF DESIGNATION OF SERIES A JUNIOR PARTICIPATING PREFERRED STOCK OF I ea132345ex3-1_inmune.htm EX-3.1 45591
3 RIGHTS AGREEMENT, DATED AS OF DECEMBER 30, 2020, BY AND BETWEEN INMUNE BIO INC. ea132345ex4-1_inmune.htm EX-4.1 479529
  Complete submission text file 0001213900-20-045464.txt   601665
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 201426452
SIC: 2836 Biological Products, (No Diagnostic Substances)